Division of Medicaid Services September 11, 2019 1:00 PM to 4:00 PM 1 W. Wilson Street, Room B370 Madison, Wisconsin 53701 AGENDA 1 WEST WILSON STREET MADISON, WI 53703 1:00-1:20 Welcome and Introductions Susan Seibert 1:20-1:25 Review of the Agenda and Board Materials Susan Seibert 1:25-1:30 1:30-2:00 Approval of Minutes: June 5, 2019 Updates Susan Seibert Lynn Radmer, RPh • Quarterly Reports • Patient Age • Therapeutic Duplication • Opioid/Benzodiazepine Intervention • Naloxone Intervention • DUR Annual Report 2:00-2:15 2:15-2:30 2:20-2:45 Benzodiazepines, Buspirone and SSRIs/SNRIs Break Antipsychotics Use in Children Lynn Radmer, RPh Randy Cullen, MD Lynn Radmer, RPh 2:45-3:30 SUPPORT Act Discussion Lynn Radmer, RPh Susan Seibert 3:30-3:45 Dental Discussion Lynn Radmer, RPh Russ Dunkel, DDS 3:45-4:00 Retrospective DUR Process Review Katie Counts, PharmD 4:00 Adjournment Susan Seibert The purpose of this meeting is to conduct the governmental business outlined in the above agenda. The Drug Utilization Review Board is a federally mandated Board which meets on a quarterly basis to review and make recommendations to the Department on predetermined standards for retrospective and prospective drug utilization. DHS is an equal opportunity employer and service provider. If you need accommodations because of a disability, if you need an interpreter or translator, or if you need this material in another language or in alternate format, you may request assistance to participate by contacting Katie Counts at (334) 521-4714 ext. 4937.
Reasonable accommodations, including the provision of informational material in an alternative format, will be provided for qualified individuals with disabilities upon request. This agency, to the maximum extent possible, holds all meetings in facilities that are physically accessible to persons with disabilities. For questions about accessibility, contact the meeting's sponsoring division.